No Data
No Data
No Data
No Data
No Data
Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Profits May Not Reveal Underlying Issues
The market for Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) stock was strong after it released a healthy earnings report last week. However, we think that shareholders should be cautious
Simply Wall StMay 1 18:34 ET
Jiuzhou Pharmaceutical (603456.SH) reported first-quarter results, net profit of 237 million yuan, a year-on-year decrease of 15.65%
Jiuzhou Pharmaceutical (603456.SH) released its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
Zhitong FinanceApr 24 05:22 ET
Jiuzhou Pharmaceutical (603456.SH): Japanese CRO mainly focuses on innovative drug CMC business
Gelonghui, April 16 | Jiuzhou Pharmaceutical (603456.SH) said on the investor interactive platform that Japan's CRO company mainly focuses on innovative drug CMC business and is expected to be put into use in the third quarter of 2024.
Gelonghui FinanceApr 16 06:24 ET
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Analysts Just Slashed This Year's Estimates
The analysts covering Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for thi
Simply Wall StApr 14 20:38 ET
Jiuzhou Pharmaceutical (603456.SH): Net profit increased 12.17% year-on-year in 2023, and plans to pay 10 to 5 yuan
Gelonghui, April 8, 丨 Jiuzhou Pharmaceutical (603456.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 5,523 billion yuan, an increase of 1.44%; net profit attributable to shareholders of listed companies was 1,033 billion yuan, up 12.17% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,024 million yuan, up 10.46% year on year; and basic earnings per share. It is proposed to distribute a cash dividend of 5.00 yuan (tax included) for every 10 shares to all shareholders.
Gelonghui FinanceApr 8 06:11 ET
Jiuzhou Pharmaceutical Gets Nod to Market Sitagliptin Metformin Tablets; Shares Drop 4%
Zhejiang Jiuzhou Biopharmaceutical, a unit of Zhejiang Jiuzhou Pharmaceutical (SHA:603456), obtained a drug registration certificate from China's National Medical Products Administration for its sitag
MT NewswiresApr 8 01:50 ET
No Data
No Data